Peptron (087010) closed at the limit-down price as the company once again addressed the controversy surrounding the termination of its technology evaluation agreement with Eli Lilly. Peptron emphasized that the joint research was completed normally and stated that the absence of a follow-up commercialization contract should not be interpreted as the collapse of the collaboration.

■ Down 29.94% from the Previous Day... Closed at 91,500 Won

On the 8th, Peptron's share price fell 39,100 won (-29.94%) from the previous day to close at 91,500 won. With the stock plunging to the daily limit, investors' attention focused on how the partnership with Eli Lilly would unfold going forward.

■ SmartDepot™ Technology Evaluation Agreement Ended on the 7th... 'Completed Normally'

What drew market attention was the SmartDepot™ platform technology evaluation agreement that ended on the 7th. Peptron explained that the recently concluded procedure was the joint research and evaluation process under the technology evaluation agreement signed with Eli Lilly. The two companies completed the research and evaluation normally within the agreed contract period, and Peptron stated that it received all compensation due under the contract.

■ "No Commercialization Contract Signed, But That Doesn't Mean Cooperation Possibilities Are Gone"

The notable point is the follow-up commercialization contract. The company acknowledged that no separate commercialization contract had been signed as of the end of the technology evaluation. However, it maintained the position that it is inappropriate to conclude that future cooperation possibilities have disappeared merely because the contracts were not signed simultaneously. This is why Peptron issued the additional guidance, making clear that the normal termination of the technology evaluation agreement and the failure to conclude a commercialization contract are not the same thing.

■ Remaining Questions... Commercialization Feasibility and Terms

However, from investors' perspective, questions remain. It has not yet been concretely confirmed whether the completed technology evaluation will actually lead to commercialization, and if so, in what form and under what conditions.

Peptron explained that in order to use the technology evaluation results for actual product development, commercial viability as well as mass producibility, marketability, and intellectual property must be comprehensively reviewed. This means that even after the technical evaluation is complete, a separate process is required for commercial decision-making. The fact that research results have been secured and the signing of a new contract based on them should be examined as distinct matters.

The company stated that it will continue activities to enhance the business value of the SmartDepot™ platform and focus on business development to connect it to actual product development and commercialization results. However, even in this additional guidance, the timing, scale, or specific terms of a follow-up commercialization contract were not presented.

■ Market Focus on 'Tangible Progress'

Ultimately, what the market needs to see is not merely the fact that the technology evaluation ended normally, but whether tangible progress emerges in actual commercialization negotiations. The future direction of Peptron's share price, which hit the limit down, may also depend on how much of this uncertainty is resolved.

Peptron stated that if any matters are concretely determined in the future, it will provide guidance in accordance with relevant laws and procedures.

[This article was written based on provided stock price information and the company's announcement. The completion of the technology evaluation does not imply the signing of a follow-up commercialization contract, and whether such a contract will be concluded in the future remains undecided. The stock market involves high volatility, and this article is not an investment solicitation. Investment decisions and responsibilities rest with the investor. This article was written with the assistance of AI.]